These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6983890)

  • 21. The self determinants recognized by human virus-immune T cells can be distinguished from the serologically defined HLA antigens.
    Biddison WE; Ward FE; Shearer GM; Shaw S
    J Immunol; 1980 Feb; 124(2):548-52. PubMed ID: 6153199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural analysis of HLA-A2 antigen from immunoselected mutant 8.6.1: further definition of an HLA-A2-specific serological determinant.
    Taketani S; Krangel MS; Pious D; Strominger JL
    J Immunol; 1983 Dec; 131(6):2935-8. PubMed ID: 6196407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-A2 mutants immunoselected in vitro. Definition of residues contributing to an HLA-A2-specific serological determinant.
    Krangel MS; Taketani S; Pious D; Strominger JL
    J Exp Med; 1983 Jan; 157(1):324-36. PubMed ID: 6184441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. II. Definition of three HLA-A2 subtypes by CTLs.
    van der Poel JJ; Pool J; Goulmy E; van Rood JJ
    Immunogenetics; 1983; 17(6):599-608. PubMed ID: 6190741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule.
    Brenner MB; McLean J; Yang SY; van der Poel JJ; Pious D; Strominger JL
    J Immunol; 1985 Jul; 135(1):384-90. PubMed ID: 2582041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
    Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
    J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of localized HLA class II beta chain polymorphism on binding of antigenic peptide and stimulation of T cells.
    Newton-Nash DK; Eckels DD
    Hum Immunol; 1992 Mar; 33(3):213-23. PubMed ID: 1618659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfer of HLA antigens from stimulatory B cells to alloreactive T lymphocytes: a novel mechanism of "allospecific" autoregulation.
    Liu K; Zeevi A; Duquesnoy RJ
    Transplant Proc; 1999; 31(1-2):726-7. PubMed ID: 10083310
    [No Abstract]   [Full Text] [Related]  

  • 29. Determinants recognized by human cytotoxic T cells on a natural hybrid class I HLA molecule.
    Clayberger C; Holmes N; Wang PL; Koller TD; Parham P; Krensky AM
    J Exp Med; 1985 Nov; 162(5):1709-14. PubMed ID: 2414389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
    Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes.
    Peiper M; Goedegebuure PS; Alldinger I; Knoefel WT; Izbicki JR; Eberlein TJ
    Anticancer Res; 2002; 22(6A):3357-63. PubMed ID: 12530087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.
    Alexander-Miller MA; Parker KC; Tsukui T; Pendleton CD; Coligan JE; Berzofsky JA
    Int Immunol; 1996 May; 8(5):641-9. PubMed ID: 8671651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex.
    Heemskerk MH; de Paus RA; Lurvink EG; Koning F; Mulder A; Willemze R; van Rood JJ; Falkenburg JH
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6806-11. PubMed ID: 11381117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of HLA-A2 and -B7 antigens by cloned cytotoxic T lymphocytes after gene transfer into human and monkey, but not mouse, cells.
    Barbosa JA; Mentzer SJ; Minowada G; Strominger JL; Burakoff SJ; Biro PA
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7549-53. PubMed ID: 6390442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
    Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
    J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.
    Bjorkman PJ; Saper MA; Samraoui B; Bennett WS; Strominger JL; Wiley DC
    Nature; 1987 Oct 8-14; 329(6139):512-8. PubMed ID: 2443855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
    Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
    Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a B lymphoblastoid cell line mutant that secretes HLA-A2.
    Krangel MS; Pious D; Strominger JL
    J Immunol; 1984 Jun; 132(6):2984-91. PubMed ID: 6609965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.
    Hogan KT; Shimojo N; Walk SF; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Exp Med; 1988 Aug; 168(2):725-36. PubMed ID: 3261776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.